How to treat aggressive prostate cancer with PSA 45?

Hello,

Welcome to icliniq.com.

I understand your concern.

This is a complex case that requires careful consideration of multiple factors. A Gleason score of 4+5=9 and a PSA (prostate-specific antigen) of 45 indicate high-risk, potentially locally advanced prostate cancer. Previous radiation therapy limits the use of external beam radiation therapy (EBRT) due to concerns about toxicity, including an increased risk of fibrosis, bowel/bladder complications, and secondary malignancies.

Radical prostatectomy is a definitive treatment option; however, the high-risk nature of the disease raises concerns about the potential need for adjuvant therapy. If extracapsular extension or lymph node involvement is present, additional adjuvant radiation or androgen deprivation therapy (ADT) may be necessary. A combination of EBRT and ADT is a standard approach for high-risk prostate cancer. However, if prior radiation fields overlap with prostate treatment, toxicity risks must be carefully evaluated. Radical prostatectomy with extended pelvic lymph node dissection is the preferred approach if prior radiation makes additional radiation risky.

In summary:

1. If prior radiation is not a contraindication: Radical prostatectomy + EBRT + ADT.
2. If prior radiation poses a risk: Radical prostatectomy with extended pelvic lymph node dissection.

Additionally, anticoagulation therapy increases perioperative bleeding risks. A cardiology consultation is essential before surgery to determine whether anticoagulation can be safely paused and when to stop and restart the medication. Your anesthesiologist must be fully informed about all your medical conditions before surgery.

I hope this helps you.

Thank you.